US Patent Issued to FULL-LIFE TECHNOLOGIES HK on Feb. 4 for "Cleavable radioligands for targeting cell surface receptors and uses thereof" (Canadian, American Inventors)

ALEXANDRIA, Va., Feb. 5 -- United States Patent no. 12,214,059, issued on Feb. 4, was assigned to FULL-LIFE TECHNOLOGIES HK Ltd. (Hong Kong).

"Cleavable radioligands for targeting cell surface receptors and uses thereof" was invented by Fa Liu (Watchung, N.J.) and Alla Darwish (Kitchener, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application relates to a compound or a pharmaceutically acceptable salt and/or solvate thereof comprising one or more circulation enhancing groups, one or more target binding groups, one or more chelating groups, at one least cleavable linker and at least one branching group that is at least trivalent. The application further includes a radionuclide complex o...